2019 Speakers

 
 

Mohamed Abou El Enein, Head of Department, Charite Universitatsmedizin

Mohamed Abou El Enein at World Advanced Therapies & Regenerative Medicine Congress 2019

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Diego Ardigo at World Advanced Therapies & Regenerative Medicine Congress 2019

Stephen Badylak, Deputy Director, McGowan Institute for Regenerative Medicine, University of Pittsburgh

Stephen Badylak at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Dr Roy Baynes at World Advanced Therapies & Regenerative Medicine Congress 2019

Robert Beckman, Managing Partner, The Channel Group, LLC

Robert Beckman at World Advanced Therapies & Regenerative Medicine Congress 2019

Cristiana Boi, Researcher, University of Bologna

Cristiana Boi at World Advanced Therapies & Regenerative Medicine Congress 2019

John Campbell, Professor and Associate Director, Scottish National Blood Transfusion Service

John Campbell at World Advanced Therapies & Regenerative Medicine Congress 2019

Manuel Carrondo, Vice President, I.B.E.T.

Manuel Carrondo at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Yen Choo, Chief Executive Officer, Progenitor Therapeutics

Dr Yen Choo at World Advanced Therapies & Regenerative Medicine Congress 2019

Davide Danovi, King's College London

Davide Danovi at World Advanced Therapies & Regenerative Medicine Congress 2019

Francesco Dazzi, Professor of Regenerative and Hematological Medicine, King's College London

Francesco Dazzi at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Robert Deans, CTO, Blue Rock Therapeutics

Dr Robert Deans at World Advanced Therapies & Regenerative Medicine Congress 2019

Simone Dimartino, Lecturer, Institute for Bioengineering, University of Edinburgh

Simone Dimartino at World Advanced Therapies & Regenerative Medicine Congress 2019

Dominik Egger, University Assistant, University of Natural Resources and Life Sciences

Dominik Egger at World Advanced Therapies & Regenerative Medicine Congress 2019

Jim Fackler, Associate Professor of Anesthesiology and Critical Care Medicine, John Hopkins School Of Medicine

Jim Fackler at World Advanced Therapies & Regenerative Medicine Congress 2019

Dan Grant, CEO, MTP Connect

Pascale Guillot, Senior Lecturer of Fetal and Maternal Health, University College London

Pascale Guillot at World Advanced Therapies & Regenerative Medicine Congress 2019

Hansjörg Hauser, Head of Dept. of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Hansjörg Hauser at World Advanced Therapies & Regenerative Medicine Congress 2019

Frank Hecht, Vice President Marketing and Sales, CellGenix GmbH

Frank Hecht at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Ian Hudson, Chief Executive Officer, Medicines and Healthcare Products Regulatory Agency

Dr Ian Hudson at World Advanced Therapies & Regenerative Medicine Congress 2019

Ohad Karnieli, Chief Executive Officer and Co Founder, Atvio Biotechnology

Ohad Karnieli at World Advanced Therapies & Regenerative Medicine Congress 2019

Cornelia Kasper, Professor, Biopharmaceutical Production and Technology, B.O.K.U.

Cornelia Kasper at World Advanced Therapies & Regenerative Medicine Congress 2019

Sven Kili, Vice President and Head of Gene Therapy Development, GlaxoSmithKline

Sven Kili at World Advanced Therapies & Regenerative Medicine Congress 2019

Jean-Pierre Latere, COO, Celyad

Jean-Pierre Latere at World Advanced Therapies & Regenerative Medicine Congress 2019

Jane Lebkowski, President of Research and Development, Regenerative Patch Technologies

Jane Lebkowski at World Advanced Therapies & Regenerative Medicine Congress 2019

Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics Inc

Chaim Lebovits at World Advanced Therapies & Regenerative Medicine Congress 2019

Michael Linden, Former VP Gene Therapy & Head, GMI, Pfizer Ltd

Michael Linden at World Advanced Therapies & Regenerative Medicine Congress 2019

Giovanna Lombardi, Professor of Human Transplant Immunobiology, King's College London

Giovanna Lombardi at World Advanced Therapies & Regenerative Medicine Congress 2019

Ross Macdonald, Chief Executive Officer, Cynata Therapeutics Ltd

Ross Macdonald at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Danilo Maddalo, Laboratory Head, Novartis Institutes for Biomedical Research

Dr Danilo Maddalo at World Advanced Therapies & Regenerative Medicine Congress 2019

John Maher, Chief Scientific Officer, Leucid Bio

John Maher at World Advanced Therapies & Regenerative Medicine Congress 2019

Marcello Maresca, Associate Director, Astrazeneca Ab

Marcello Maresca at World Advanced Therapies & Regenerative Medicine Congress 2019

Giuseppe Mazza, Chief Executive & Scientific Officer, Engitix

Giuseppe Mazza at World Advanced Therapies & Regenerative Medicine Congress 2019

Ian Mckay, ‎Innovation Lead Advanced Therapies, Innovate UK

Ian Mckay at World Advanced Therapies & Regenerative Medicine Congress 2019

Nick Medcalf, Innovation Lead - Advanced Therapies, Innovate UK

Nick Medcalf at World Advanced Therapies & Regenerative Medicine Congress 2019

Stefano Menegatti, Assistant Professor in Chemical and Biomolecular Engineering, North Carolina State University

Stefano Menegatti at World Advanced Therapies & Regenerative Medicine Congress 2019

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences

Joanna Miller at World Advanced Therapies & Regenerative Medicine Congress 2019

Claudia Mitchell, Chief Executive Officer, Universal Cells

Claudia Mitchell at World Advanced Therapies & Regenerative Medicine Congress 2019

Neill Moray Mackenzie, Chairman & Board Mamber, Cellular Therapeutics Ltd

Neill Moray Mackenzie at World Advanced Therapies & Regenerative Medicine Congress 2019

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Mary Murphy at World Advanced Therapies & Regenerative Medicine Congress 2019

Prof Norio Nakatsuji, Chief Advisor, Kyoto University

Prof Norio Nakatsuji at World Advanced Therapies & Regenerative Medicine Congress 2019

Cecil Nick, Vice President, PAREXEL

Jelena Ochs, Head of the Business Unit for Life Sciences Engineering, Fraunhofer Institute for Production Technology

Jelena Ochs at World Advanced Therapies & Regenerative Medicine Congress 2019

Ioannis Papantoniou, ATMP Bioprocessing Coordinator, KU Leuven

Ioannis Papantoniou at World Advanced Therapies & Regenerative Medicine Congress 2019

Detlev Parow, Head of Department of Medicines, Therapeutic Appliances and Remedies, D.A.K.

Detlev Parow at World Advanced Therapies & Regenerative Medicine Congress 2019

Vivienne Parry, Head of Engagement, Genomics England

Vivienne Parry at World Advanced Therapies & Regenerative Medicine Congress 2019

Sergey Piletsky, Professor, University of Leicester

Sergey Piletsky at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Qasim Rafiq, Associate Professor, Bioprocessing of Cell and Gene Therapies, University College London

Dr Qasim Rafiq at World Advanced Therapies & Regenerative Medicine Congress 2019

Ajan Reginald, CEO, Celixir

Dr Barry Rosen, Senior Principal Scientist/Director, AstraZeneca

Dr Barry Rosen at World Advanced Therapies & Regenerative Medicine Congress 2019

Mark W. Sawicki, Ph.D, Chief Commercial Officer, Cryoport Inc

Benjamin Shepherd, Associate Director of R&D, Therapeutics, Organovo

Benjamin Shepherd at World Advanced Therapies & Regenerative Medicine Congress 2019

David Sloman, Chief Executive Officer, Royal Free London NHS Foundation Trust

David Sloman at World Advanced Therapies & Regenerative Medicine Congress 2019

Devyn Smith, Chief Operations Officer And Head Of Strategy, Sigilon

Devyn Smith at World Advanced Therapies & Regenerative Medicine Congress 2019

Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics

Eric Soller at World Advanced Therapies & Regenerative Medicine Congress 2019

Sanja Stifter Md, Phd, Professor, Department of Pathology, Faculty of Medicine, University of Rijeka

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Prima Biomed, Ltd

Dr Frédéric Triebel at World Advanced Therapies & Regenerative Medicine Congress 2019

Marc Turner, Medical Director, Scottish National Blood Transfusion Service

Marc Turner at World Advanced Therapies & Regenerative Medicine Congress 2019

Alain Vertes, Vice President, Alliance Management, Mesoblast Inc

Alain Vertes at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Ivan Wall, Reader in Department of Biochemical Engineering, Aston University

Dr Ivan Wall at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Michael D West, Ph.D., Chief Executive Officer and Director, BioTime, Inc.

Dr Michael D West, Ph.D. at World Advanced Therapies & Regenerative Medicine Congress 2019

David Johannes Wurm, Project Assistant of Biochemical Engineering, Vienne University of Technology

David Johannes Wurm at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Mark Zimmerman, Vice President, Business Development and Strategy, ViaCyte

Dr Mark Zimmerman at World Advanced Therapies & Regenerative Medicine Congress 2019
 

DOWNLOAD PROSPECTUS

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com